Premium
This is an archive article published on October 27, 2012

SPARC Q2 net loss at Rs 24 crore

Sun Pharma Advanced Research Company (SPARC) today posted a net loss of Rs 24.12 crore.

Sun Pharma Advanced Research Company (SPARC) today posted a net loss of Rs 24.12 crore for the second quarter ended September 30.

The company had posted a net loss of Rs 21.48 crore during the same period of previous fiscal.

Total income of the company stood at Rs 4.85 crore for the second quarter,as compared to Rs 10.17 crore during the same period of 2011-12 fiscal,SPARC said in a statement.

SPARC was demerged from Sun Pharma as a pharma research and drug discovery company in 2007.

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement